Aeromics, Simcere team up for anti-edema therapy in Greater China

Pharma |  News | 0 Comment | 06 Nov, 2019

Simcere Pharmaceutical Group and Aeromics, Inc. have announced collaboration and exclusive license agreement for AER-271, a clinical-stage anti-edema therapy, being developed for the treatm...Read more

Boehringer Ingelheim and Lilly modernise alliance

Pharma |  News | 0 Comment | 05 Nov, 2019

In a move to better serve people living with and without diabetes, Boehringer Ingelheim and Eli Lilly and Company will modernise their current alliance as of 1 January 2020 and fo...Read more

Amgen to expand oncology presence in China

Pharma |  News | 0 Comment | 05 Nov, 2019

Amgen has announced that it has entered into a strategic collaboration with BeiGene that will significantly accelerate Amgen's plans to expand its oncology presence in China, the world...Read more

Seneca Biopharma to begin trading under new ticker symbol SNCA

Pharma |  News | 0 Comment | 01 Nov, 2019

Seneca Biopharma, Inc., a clinical-stage biopharmaceutical company developing novel treatments for diseases of unmet medical need, will begin trading on the Nasdaq Capital Market under the ...Read more

Mallinckrodt, Terumo BCT announce UVADEX approval in Australia

Pharma |  News | 0 Comment | 01 Nov, 2019

Mallinckrodt plc, a global biopharmaceutical company, and Terumo BCT, a global leader in blood component, therapeutic apheresis and cellular technologies have announced that UVADEX®...Read more

Boehringer Ingelheim strengthens fight against NCDs

Pharma |  News | 0 Comment | 01 Nov, 2019

Boehringer Ingelheim, one of the world’s leading pharmaceutical companies, has announced its partnership with The Defeat-NCD Partnership, a public-private partnership anchored in the ...Read more

Taiwan FDA approves Chugai’s Hemlibra for Hemophilia A

Pharma |  News | 0 Comment | 01 Nov, 2019

Chugai Pharmaceutical has announced that Chugai Pharma Taiwan Ltd., a wholly owned subsidiary of Chugai, obtained approval from the Taiwan Food and Drug Administration (TFDA) for Hemli...Read more

AstraZeneca divests rights to Seroquel, Seroquel XR in Europe, Russia

Pharma |  News | 0 Comment | 31 Oct, 2019

AstraZeneca has agreed the sale and licence of the commercial rights to Seroquel (quetiapine fumarate immediate release) and Seroquel XR (quetiapine fumarate extended re...Read more

Pandion, Astellas collaborate for pancreas targeted immunomodulators

Pharma |  News | 0 Comment | 31 Oct, 2019

US headquartered Pandion Therapeutics, Inc., and Japan based Astellas Pharma Inc. have announced the signing of a License and Collaboration Agreement directed toward the research, developme...Read more

Lobsor Pharma receives Japanese patent for APD solution

Pharma |  News | 2 Comment | 01 Nov, 2019

Lobsor Pharmaceuticals AB, a privately held Swedish company based in Uppsala, has announced the Japanese Patent Office has issued a Decision to Grant a patent covering Lecigon® a new th...Read more

SNOMED CT Expo 2019 showcases latest in digital health

Pharma |  News | By Ankit Kankar | 0 Comment | 31 Oct, 2019

Malaysia. 31-10-2019   The SNOMED CT Expo unites clinical terminology SMEs Including Government officials . Health IT Professionals , Health Practitioners, Researchers, Academics and...Read more

Graphene 3D Patent gets approval for Trifluoroketones Synthesizing process

Pharma |  News | 0 Comment | 30 Oct, 2019

Graphene 3D Lab Inc. on 29 Oct 2019, announced that the US Patent Office has approved the issuance of the "Process for Synthesizing Trifluoroketones" patent. The Patent secures th...Read more

Tillotts partners Menarini to extend Asacol to the People’s Republic of China

Pharma |  News | 0 Comment | 29 Oct, 2019

Tillotts Pharma AG (“Tillotts”), part of the Japanese Zeria Group, and A. Menarini International Trading (Wuhan) Co. Ltd. (“Menarini”), a member of the Italian A. Me...Read more

Kazia raises A$4.0 M to progress R&D programs

Pharma |  News | 0 Comment | 29 Oct, 2019

Kazia Therapeutics Limited, an Australian oncology-focused biotechnology company, on 28 October 2019, announced that the completion of a placement of ten million new fully paid ordinary sha...Read more

Qpex Biopharma, Brii Bio target MDR infections

Pharma |  News | 0 Comment | 30 Oct, 2019

Qpex Biopharma, Inc., a biopharmaceutical company dedicated to the discovery and development of innovative anti-infective therapies, has announced that it has entered into a multi-product c...Read more

TLC announces completion of $27 M financing

Pharma |  News | 0 Comment | 28 Oct, 2019

Taiwan Liposome Company (TLC), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet medical need in pain management, ophthalmology and o...Read more

CPhI Annual Report 2019- FDA should withdraw ANDAs

Pharma |  News | 0 Comment | 28 Oct, 2019

CPhI Worldwide – the world’s largest pharma event taking place in Frankfurt (5th-7th November 2019) – has released the first part of its eponymous 2019 Annual Re...Read more

NeuroRx secures HK$ 750 M capital commitment

Pharma |  News | 0 Comment | 24 Oct, 2019

NeuroRx, Inc (NeuroRx) has signed an agreement with GEM Global Yield LLC SCS ("GEM"), the New York based private alternative investment group to provide the NeuroRx with up to&nbs...Read more